Monday, 5 July 2021

Safety lancet Market Growth, Trends and Value Chain 2020-2027

 The Safety Lancet Market is a dynamic and vital component of the healthcare industry. Developments in the medical device industry are made to simplify the diagnosis, prevention and treatment of various diseases. Every component of this industry plays an important role in the Safety Lancet Market sizing. One of such device is safety lancet, which is capturing a huge market share due to its application. The Safety Lancet Market can be further divided into push button safety lancet, pressure activated safety lancet and side button safety lancet.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/550 

The global Safety Lancet Market share is expected to reach USD 2,305.1 million in 2023 from USD 1,056.2 million in 2016 with a CAGR of 11.8% during the forecast period 2017-2023.

Key Players for Global Safety Lancet Market:

Some of the key players in this Safety Lancet Market are: F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Terumo Medical Corporation, Bayer AG, HTL-STREFA S.A., Sarstedt AG & Co., Improve Medical Technology Co. Ltd and others.

Safety Lancet Market Segments:

Global Safety lancet Market has been segmented on the basis of types which comprises of push button safety lancet, pressure activated safety lancet and side button safety lancet. On the basis of end user, it comprises of hospitals & clinics, diagnostic centers and pathology laboratories, home diagnostics and other end users.

Regional Analysis of Global Safety Lancet Market:

The global Safety Lancet Market is growing steadily. The Safety Lancet Market is growing with the CAGR of 11.8% during the forecast period from 2017-2023. Blood sampling safety lancet are the most common devices used in hospitals, clinics, diagnostic centers and home monitoring. The global safety lancet market reached USD 2,305.1 million in 2023 from 1,056.2 million in 2016. Europe region captured the largest Safety Lancet Market globally and is expected to reach USD 1,032.7 million by 2023 due to the growing demand and need for safe blood glucose tests in hospitals, clinics, diagnostics centers etc. and the growth of insulin users.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/safety-lancet-market-550 

Global Glaucoma Treatment Market size and forecast, 2020-2027

 Glaucoma is a disease characterized by fluid builds up in the front part of your eye which results in damages to the eye’s optic nerve which may lead to blindness if left untreated. Open angle glaucoma (OAG) is the most common type of glaucoma followed by closed angle glaucoma (CAG) and these two account for greater than 50% of glaucoma cases. According to World Health Organization (WHO) estimates, Glaucoma is the second most common cause of blindness worldwide after cataract. 

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2962 

The market for glaucoma is increasing at an impressive rate primarily driven by the growing number of geriatrics. Older population has higher risk of developing glaucoma although other age groups may be affected. Other high risk groups include diabetics and those with a family history of glaucoma. The other market driving factors are increasing awareness, growing healthcare expenditure and screening etc.

The product development strategies have been very impressive with the surgery option. The last decade has seen impressive additions to the surgery options such as laser therapy, photodynamic therapy etc. The market constraints are excellent efficacy and efficiency of present drugs especially prostaglandin analogs and carbonic anhydrase inhibitors, which has set the bar for a new therapy extremely high and the loss of patent protection on the major drugs used to treat glaucoma.

Taking all factors into consideration, we expect the Asia Pacific glaucoma treatment market to reach around $ 888.94 million in 2023 from 6.0 million in 2017, by the end of the forecast period at a CAGR of ~ 7.5 %. While the glaucoma drug market will grow by a flat CAGR of 2.1% the glaucoma surgery market is poised for an explosive CAGR of 18.5 %.

Key Players for Asia-Pacific Glaucoma Treatment Market:

Some of the key players in this Asia-Pacific Glaucoma Treatment Market share are: Novartis AG, Pfizer Inc., Allergan, Merck & Co., Ocular Therapeutix Inc, pSivida Corp, Icon Bioscience Inc, Amorphex Therapeutics LLC., Ellex, Quantel, Lumenis, and Lightmed among others.

Segments:

Asia-Pacific Glaucoma Treatment Market has been segmented on the basis of disease indication which comprises Closed Angle Glaucoma (CAG), open angle glaucoma (OAG), secondary glaucoma, congenital glaucoma and other. On the basis of drug class; market is segmented into prostaglandin analogs (PGAS), alpha agonist, beta blockers, cholinergic drugs, carbonic anhydrase inhibitors, and others. On the basis of surgery; market is segmented into laser iridotomy, laser trabeculoplasty, aqueous shunt surgery and peripheral iridectomy. On the basis of end users; market is segmented into hospitals and home users.

Regional Analysis of Asia-Pacific Glaucoma Treatment Market:

The healthcare sector of Asia Pacific varies immensely by countries. However the Asia Pacific region has lower public sector expenditure and most treatments involve out of pocket expenditure. Further the eye care has been a neglected segment especially in the poor countries of Asia Pacific region. Japan and South Korea are the leading markets while China will be the fastest growing due to rising healthcare expenditure and faster economic growth. Also the presence of strong generics especially in nations like India will lead to volume growth of anti-glaucoma drugs. The surgery market however will see fastest growth in Japan as compared to developing parts of Asia Pacific.

The report for Asia-Pacific Glaucoma Treatment Market of Market Research Future comprises extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/asia-pacific-glaucoma-treatment-market-2962 

Sunday, 4 July 2021

Surgical Drapes and Gowns Market to Witness Widespread Expansion During 2020-2027

 Global surgical drapes and gowns market is expected to grow significantly over the forecast period. It is anticipated that the market held value of USD 2.23 billion in 2017 and is projected to grow at a CAGR of 4.4% over the forecast period.

The factors such as increasing number of surgeries and high incidences of hospital-acquired infections are expected to propel the growth of the market. However, reuse of surgical drapes and gowns in developing regions hamper the market growth over the forecast period.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7122

Segmentation

The global surgical drapes and gowns market has been segmented into type, usage pattern, and end user.

Based on type, surgical drapes and gowns market is segmented into surgical drapes and surgical gowns. The surgical drapes segment is expected to account for the largest share segment of the market in 2017.

Based on usage pattern, surgical drapes and gowns market is segmented into disposable surgical drapes & gowns and reusable surgical drapes & gowns.

Based on end user, surgical drapes and gowns market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment is expected to account for the largest share segment of the market in 2017.

The surgical drapes and gowns market segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The surgical drapes and gowns market in the Americas further segmented into North America and South America, with the North American market divided into the US and Canada.

The European surgical drapes and gowns market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The surgical drapes and gowns market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The surgical drapes and gowns market in the Middle East & Africa segmented into the Middle East and Africa.

Key players

Halyard Health (US), Cardinal Health (US), 3M (US), Mölnlycke Health Care (Sweden), Thermo Fisher Scientific (US), STERIS Corporation (US), Paul Hartmann AG (Germany), Pacon Manufacturing (US), Medica Europe B.V. (The Netherlands), and Guardian (US) are some of the key players in the global surgical drapes and gowns market.

Regional Market Summary

Geographically, the Americas is anticipated to dominate the global surgical drapes and gowns market owing to a well-established player and increasing surgical procedures.

Europe is expected to hold the second largest position in the global surgical drapes and gowns market. The market growth in this region is attributed to the growth in surgical procedures.

The surgical drapes and gowns market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region.

The Middle East & Africa has the least share of the surgical drapes and gowns market

Surgical Microscopes Market Growth, Trends and Value Chain 2020-2027

 The global surgical microscopes market is expected to grow significantly over the forecast period. The market held a market value of USD 574.34 million in 2017 and is projected to grow at a CAGR of 11.63% over the forecast period.

Surgical microscopes are the optical microscopes specially designed for the use in surgical settings. These surgical microscopes have a high magnification resolution which is highly beneficial during the microsurgeries. Also, surgical microscopes can be customized which is helpful for the component sterilization, and disinfection to ensure the complete cross-infection control. Generally, even the basic surgical microscopes can cost up to several thousand dollars. The advanced versions of such microscopes have high price points. There are several factors that fuel the growth of the global surgical microscopes market. These include, increasing number of surgical procedures, high demand for the minimally invasive surgeries, and continuous development in the medical sector to come up with better surgical approaches. Moreover, development of customized microscopy solutions, and increasing use of fluorescence image-guided surgery (FIGS) is expected to boost the growth of the market during the forecast period.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7065

On the other hand, there are several factors such as high cost of the microscopic devices, stringent regulatory norms, and lack of required medical infrastructure in the developing and underdeveloped regions which are likely to thwart the growth of the surgical microscopes market to an extent.

Segmentation

The global surgical microscopes market has been segmented into type, application and end user.

Based on types, the market has been segmented into, On casters microscopes, wall mounted microscopes, table top microscopes, and ceiling mounted microscopes. The on casters microscopes segment is expected to account for the largest share in the global surgical microscopes market in 2017. This large share is majorly attributed to its convenience in the use as compared to other products.

Based on application, the market has been segmented into neurosurgery & spine surgery, ophthalmology, ENT surgery, dentistry, oncology, plastic & reconstructive surgery, urology, gynecology, and other. The neurosurgery & spine surgery segment is expected to account for the largest share in the global surgical microscopes market in 2017 followed by ophthalmology segment.

Based on end users, the market has been segmented into hospitals, physician’s clinic, academic and research institutes, and other outpatient settings. The hospitals segment is expected to account for the largest share in the global surgical microscopes market in 2017. At the same time, the high awareness about the aesthetics, dental hygiene and increasing rate of ophthalmic surgical cases in the developed and developing countries has led physician’s clinic segment to grow at the fastest rate during the forecast period.

Based on the regions, the market for surgical microscopes is segmented in to, the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The surgical microscopes market in the Americas region has further been segmented into North America and South America, where-in the North American market is further divided into the US and Canada.

European surgical microscopes market has been segmented into Western Europe and Eastern Europe where-in Western Europe region is further divided into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The surgical microscopes market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The surgical microscopes market in the Middle East & Africa has been segmented into regions such as the Middle East & Africa.

Key players

Accu-Scope Inc., Alltion (Wuzhou) Co., Ltd., Arri Medical (Arri Group), Carl Zeiss AG, Danaher Corporation, Haag-Streit Surgical GmbH, Leica Microsystems GmbH, Novartis AG, Olympus Corporation, Seiler Precision Microscopes, Takagi Seiko Co. Ltd., and Topcon Medical Systems, Inc. are some of the key players in the global surgical microscopes market.

Pipettes, Pipettors, and Accessories Market Growth, Trends and Value Chain 2020-2027

 Global pipettes, pipettors, and accessories market is anticipated to register a healthy CAGR over the forecast period. The market held a market value of USD 1,350.0 million in 2017 and is projected to grow at a CAGR of 4.1% during the forecast period. A pipette is a laboratory tool used in laboratories to transfer a measurable amount of liquid from one container to another. These are small tubes or slender graduated tubes of glass or plastic used in laboratories to transfer a measurable volume of liquid. A pipettor is an instrument used to dispense liquid while pipetting. Factors driving the market growth are rising investment in research and development (R&D) activities, increasing demand for accuracy, productivity, and quality in healthcare companies, growing focus on improving lab throughputs, and mounting applications in life sciences and biomedical research, pharmaceutical, environmental, chemical, and food processing industries. For instance, as per the data published by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), in 2016 there were 6,861 drug entities in the preclinical regulatory phase that grew to 7,493 in 2017. In contrast, rapid development and launches of automatic and robotic-assisted liquid handling workstations are anticipated to restrain the market growth over the forecast period.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7015

Segmentation

The global pipettes, pipettors, and accessories market has been segmented into product and end user.

By product, the market has been segmented into pipettes, pipettors, and accessories. The pipettes segment is further categorized into beral/plastic/transfer/disposable pipettes, pasteur/glass pipettes/droppers, serological pipettes, volumetric/bulb pipettes, and others. The pipettors segment is sub-segmented into electronic pipettors and manual pipettors. These two pipettors are further separately categorized into single-channel pipettors and multichannel pipettors.

Based on end user, the market has been segmented into hospitals, laboratories, academic & research institutes, pharmaceutical & biotechnology companies, and others.

The global pipettes, pipettors, and accessories market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The pipettes, pipettors, and accessories market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European pipettes, pipettors, and accessories market has been segmented into Western Europe and Eastern Europe. The Western Europe pipettes, pipettors, and accessories market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The pipettes, pipettors, and accessories market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The pipettes, pipettors, and accessories market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key players

Thermo Fisher Scientific Inc., BRAND GMBH + CO KG, CAPP ApS, Thomas Scientific, Inc., Corning Incorporated, Eppendorf AG, Gilson Incorporated, Hamilton Company, Greiner Bio-One International GmbH, INTEGRA Biosciences AG, The Lab Depot, Inc., Sartorius AG, Socorex Isba S.A., Nichiryo Co.,Ltd., and Mettler-Toledo International Inc. are some of the major players in the global pipettes, pipettors, and accessories market.

Regional Market Summary

Geographically, in 2017, the Americas commanded the global pipettes, pipettors, and accessories market due to the presence of pipettes & pipettors manufacturers, advanced technology used in medical devices, rising spending on healthcare, and mounting demand for these lab supplies in the US and Canada.

Europe is also expected to hold substantial market share over the forecast period due to the rise in research & development activities, the presence of favorable government policies related to healthcare infrastructure, the availability of well-developed lab facilities, and early adoption of novel technologies.

Asia-Pacific is likely to witness fastest CAGR from 2018 to 2023 attributed to increased burden of various diseases coupled with considerable funding support for clinical research and rising interest in scientific & industrial research to create new business opportunities.

The market in the Middle East & Africa would register the modest market growth rate from 2018 to 2023. Majority of the regional market is anticipated to be governed by the Middle East region due to increasing healthcare sector reforms.

Catheter Stabilization Device Market: Drivers, Restraints, Opportunities, and Threats (2020-2027)

 Global Catheter Stabilization Device Market is expected to register a CAGR of 7.1% during the forecast period of 2018 to 2023.Catheter stabilization device are the new standard of excellence for suture-free stabilization of biliary and nephrostomy percutaneous drainage, and peritoneal lavage catheters. These devices are used to secure catheters and infusion or drainage devices and to facilitate their operations. Furthermore, growing prevalence of cardiovascular diseases is driving the growth of the market. According to the World Health Organization in 2017, cardiovascular diseases were the main cause of the deaths across the global. It was estimated that in 2015, approximately 17.7 million people died from cardiovascular diseases, repressing 31% of all the global deaths. Of these deaths, an estimated 7.4 million were due to the coronary heart diseases and 6.7 million were due to stroke. Moreover in 2017, according to the American Heart Association, 801,000 deaths in the U.S. were accounted for the cardiovascular diseases. Moreover, the global cost for cardiovascular diseases is estimated to reach USD 1044 billion by 2030 from USD 863 billion in 2010.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6944

Segmentation:

The Global Catheter Stabilization Device Market is segmented based on product type, application, end user, and region.On the basis of product type, the market is segmented into Arterial Securement Devices, Central Venous Catheter Securement Devices (further sub segmented into PICC Securement Devices, Subclavian Securement Devices, Midlines Securement Devices, Femoral Securement Devices, Portal Securement Devices, Jugular Securement Devices) Peripheral Securement Devices (further sub segmented into Foley Catheter Securement Devices, Nasogastric Tubes Securement Devices,  Endotracheal Tube Securement Devices, Ventriculoperitoneal Securement Devices, Continuous Nerve Block Catheter Securement Devices) Chest Drainage Tube Securement Devices, Abdominal Drainage Tubes Securement Devices (further sub segmented into Percutaneous Endoscopic Gastrostomy Securement Devices, Jejunal Catheter Securement Devices, Umbilical Catheter Securement Devices)Epidural Securement Devices. Further, on the basis of application the market is segmented into Cardiovascular Procedures, Respiratory Procedures, Gastric and Oropharyngeal Procedures, General Surgery, Urological Procedures, Radiology and Others. End users is segmented into Hospitals & Clinics, Home Healthcare Providers and Diagnostic Centers.

Regional Market Summary:

In the current scope of the study, the above-mentioned segments are covered into four global regions, namely- the Americas, Europe, Asia Pacific and the Middle East & Africa. The Americas dominated the Global market for catheter stabilization device owing to rising children population and presence of major market players within the region. According to the database of the U.S. Census Bureau, it was estimated that there were approximately 20,304,238 children who aged 5-9 years within the region. Moreover, the presence of developed economies and healthcare sector within the region boosts the market growth.

Europe accounted for the second largest market behind Americas. Europe consist of two regions namely Western Europe and Eastern Europe. Western Europe holds the major share of the market, which is majorly contributed by Germany, the U.K., and France. The major driving factor of the market are increasing prevalence of cardiovascular and chronic diseases. Additionally, according to the OECD, the healthcare expenditure in Germany was EUR 321 billion in 2014, which is followed by France with healthcare expenditure of EUR 237 billion. The healthcare expenditure of the U.K. in 2014 was EUR 223 billion. Healthcare organization in this region are able to afford the high cost of the treatment and devices, which has helped in driving the growth of the market. In addition to this, increasing government support and funding for the development and improving the technology have fuelled the growth of the market.

Asia Pacific is the fastest growing region in catheters market. Increasing need for better diagnostic devices, better and safe therapeutic approach, rapidly improving technology, and the presence of huge patient pool drive the growth of this market in Asia Pacific region. According to the ESCAP Statistical Database, in 2016, approximately 12.4% of the population in the Asia Pacific was over 60 years. According to the WHO, in 2013, the per capita healthcare expenditure in Australia was USD 6,110, which is followed by Japan with USD 3,966.

Catheter Stabilization Device Market Key players:

Some of the key players in the global catheter stabilization market are 3M Company, B. Braun Melsungen Ag, Baxter International, Inc., C. R. Bard, Inc., Centurion Medical Products, Convatec, Inc M.C. Johnson Company, Inc, Medtronic PLC, Merit Medical Systems, Inc, Smiths Group PLC, TIDI Products, LLC and others

Dental Surgical Instruments Market 2020 Analysis, Industry Size, Share Leaders, Current Status by Major vendors and Trends by Forecast to 2027

 Global Dental Surgical Instruments Market is expected to grow significantly over the forecast period. It is estimated that the Global Dental Surgical Instruments Market is valued at ,230 Million in 2017, with a CAGR of 6.0% during the forecast period of 2018–2023. The major factors influencing the growth of the market include increasing incidences of dental caries and other periodontal diseases, increasing number of dental professional, increasing growth dental expenditure and various others. Dental caries are the most common oral health diseases that are influencing the growth of the market. Increasing oral health problems among people are expected to increase the demand for advanced dental instruments, which is likely to enhance the market growth during the assessment period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6933

Periodontal diseases are more prevalent in the Asia-Pacific region. Lack of basic oral health education and limited availability of simple interventions such as pain relief and emergency care for acute infection and trauma to the majority of the population, especially in rural areas are major reasons for the high prevalence of periodontal diseases in the region. According to the FDI World Dental Federation, more than 80% of people in Asia including India, Bangladesh, Nepal, Malaysia, and Indonesia suffers from dental decay. Furthermore, 40 to 59% of the population in China and Australia suffers from dental decay. This high prevalence of dental decay triggers the demand for dental instruments, which in turn makes Asia pacific the fastest growing market.

However, factors such as high cost dental instruments and inadequate reimbursement policies for dental surgeries are expected hamper the growth of the market

Segmentation:

The Global Dental Surgical Instruments Market has been segmented into product type, therapeutic area, and end user.The market, on the basis of product type, has been segmented into instruments, and consumables. Furthermore, instruments have been segmented into handheld instruments, handpieces, lasers, electrosurgical systems, ultrasonic instruments. Moreover, handpieces are segmented into air-driven handpieces, electric handpieces & hybrid handpieces and lasers are segmented into soft-tissue lasers, & all-tissue lasersThe market, by therapeutic area, has been segmented into restorative dentistry, orthodontics, endodontics, and others.

The market, by end user, has been segmented into hospitals and dental clinics and others. The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Dental Surgical Instruments Market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European Dental Surgical Instruments Market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The dental surgical instruments market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Dental Surgical Instruments Market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key players:

3M Company, A-Dec Inc.,  AMD Lasers, B. Braun Melsungen AG, Biolase, Inc., Brasseler USA, CAO Group, Inc., Coltene Holding AG, Danaher Corporation, Dentsply Sirona Inc., Helmut Zepf Medizintechnik GmbH, Hu-Friedy Manufacturing Company, LLC, Integra Lifesciences Holdings Corporation, Nakanishi Inc., Prima Dental Manufacturing Ltd., The Yoshida Dental Mfg. Co., Ltd.  among others are some of the key players in the Global Dental Surgical Instruments Market.

Regional Market Summary

Geographically, the Americas is anticipated to dominate the Global Dental Surgical Instruments Market. The large size of the market can be attributed to the higher adoption of various dental devices coupled with the presence of technologically advanced products. Earlier, periodontists were purchasing hospital format cyanoacrylate adhesive items that were intended for single-use wound closure circumstances in an emergency room setting. The formulations and packaging were not customized to the necessities of the dental industry. Moreover, the high disposable income of the region also enables professionals to opt for such devices. The occurrence of periodontal disease is on the rise in the US. According to the 2015 report suggested by the Centers for Disease Control and Prevention (CDC), nearly 47.2% of adults have some form of periodontal disease. It is also reported that the condition is more common in men than women. The healthcare transmission framework is changing quickly with the execution of the Affordable Care Act.

Europe is expected to hold the second largest position in the Global Dental Surgical Instruments Market.

Asia-Pacific is anticipated to be the fastest growing region in the market due to the presence of a huge dental patient population, continuously developing economies, and various others.

On the other hand, the Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to growing healthcare expenditure.